Dilon Technologies
Newport News
About Dilon Technologies
Dilon Technologies aids in the early detection of breast cancer when mammograms are inconclusive. It is an ideal complement to mammography for women with dense breasts, questionable mammograms, and a family history of breast cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $18.5M
- Funding stage: Private Equity
- Last round: Private Equity (Jun 2025)
- Website: dilon.com
- Phone: 757-269-4910
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/dilon-technologies-45506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.